Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abeona Therapeutics

5.29
+0.36507.42%
Volume:783.69K
Turnover:4.03M
Market Cap:256.50M
PE:-3.40
High:5.30
Open:4.94
Low:4.90
Close:4.92
Loading ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 Mar

Abeona Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Feb

Abeona Therapeutics Inc.'s (NASDAQ:ABEO) Shift From Loss To Profit

Simply Wall St.
·
07 Feb

BRIEF-Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
03 Feb

Abeona Therapeutics announces new employee inducement grants

TIPRANKS
·
03 Feb

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 Feb

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 Feb

BRIEF-Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
31 Dec 2024

Abeona Therapeutics announces employee inducement grants

TIPRANKS
·
31 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
31 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
31 Dec 2024

Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO),

Simply Wall St.
·
28 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 Dec 2024

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
02 Dec 2024

DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ACCESSWIRE
·
27 Nov 2024

Abeona Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
25 Nov 2024

Positive Outlook for Abeona Therapeutics: FDA Acceptance and Strategic Initiatives Reinforce Buy Rating

TIPRANKS
·
25 Nov 2024

ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50…

Zacks Small Cap Research
·
19 Nov 2024

Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

GuruFocus.com
·
15 Nov 2024

Abeona Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
14 Nov 2024